Foundation for Innovative New Diagnostics-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Foundation for Innovative New Diagnostics - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014016
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured project management framework, product development services, buruli ulcer diagnosis, chagas disease diagnostic solutions, hat diagnostic solutions, and tuberclosis diagnostic solutions. FIND also provides malaria therapy programs, neglected tropical diseases therapy programs, tuberculosis therapy programs, HIV therapy programs, and cross-cutting themes solutions. The organization has its presence in Switzerland, India, Uganda, and South Africa. FIND is headquartered in Geneva, Switzerland.

Foundation for Innovative New Diagnostics – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Foundation for Innovative New Diagnostics, Medical Devices Deals, 2011 to YTD 2017 9
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Janssen Pharma Enters into Agreement with Foundation for Innovative New Diagnostics 11
Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 12
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 13
Foundation for Innovative New Diagnostics – Key Competitors 14
Foundation for Innovative New Diagnostics – Key Employees 15
Foundation for Innovative New Diagnostics – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Key Facts 2
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Foundation for Innovative New Diagnostics, Deals By Therapy Area, 2011 to YTD 2017 8
Foundation for Innovative New Diagnostics, Medical Devices Deals, 2011 to YTD 2017 9
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Janssen Pharma Enters into Agreement with Foundation for Innovative New Diagnostics 11
Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 12
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 13
Foundation for Innovative New Diagnostics, Key Competitors 14
Foundation for Innovative New Diagnostics, Key Employees 15
Foundation for Innovative New Diagnostics, Other Locations 16

★海外企業調査レポート[Foundation for Innovative New Diagnostics-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • National Real Estate Company K.S.C.:企業の戦略・SWOT・財務情報
    National Real Estate Company K.S.C. - Strategy, SWOT and Corporate Finance Report Summary National Real Estate Company K.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Aurora National Life Assurance Company:企業の戦略・SWOT・財務情報
    Aurora National Life Assurance Company - Strategy, SWOT and Corporate Finance Report Summary Aurora National Life Assurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Scynexis Inc (SCYX):製薬・医療:M&Aディール及び事業提携情報
    Summary Scynexis Inc (Scynexis) is a pharmaceutical company that discovers, develops and commercializes novel anti-infective for various therapeutic needs. The company provides pipeline products such as SCY-078, is used for invasive fungal infections; SCY-635, is used for the treatment of Hepatitis …
  • Southern California Gas Co:企業の戦略的SWOT分析
    Southern California Gas Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • AB SKF (SKF B):企業の財務・戦略的SWOT分析
    AB SKF (SKF B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • ShotSpotter Inc (SSTI):企業の財務・戦略的SWOT分析
    ShotSpotter Inc (SSTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Citrix Systems Inc (CTXS):企業の財務・戦略的SWOT分析
    Citrix Systems Inc (CTXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Jungheinrich AG:戦略・SWOT・企業財務分析
    Jungheinrich AG - Strategy, SWOT and Corporate Finance Report Summary Jungheinrich AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • SunEdison Inc (SUNEQ)-エネルギー分野:企業M&A・提携分析
    Summary SunEdison, Inc. (SunEdison) is a solar energy company that develops and sells photovoltaic energy solutions, and owns and operates clean power generation assets. The company also develops, manufactures and sells silicon wafer for the semiconductor industry. It also offers solar energy servic …
  • The Nisshin OilliO Group Ltd (2602):企業の財務・戦略的SWOT分析
    The Nisshin OilliO Group Ltd (2602) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Zweites Deutsches Fernsehen:企業の戦略的SWOT分析
    Zweites Deutsches Fernsehen - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Therapix Biosciences Ltd (TRPX):企業の財務・戦略的SWOT分析
    Therapix Biosciences Ltd (TRPX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Zhejiang Hisun Pharmaceutical Co Ltd (600267):企業の財務・戦略的SWOT分析
    Summary Zhejiang Hisun Pharmaceutical Co Ltd (Hisun) manufactures and commercializes drugs to treat tumor, infections, cardiovascular, endocrine, depression and orthopaedic disorders. The company’s product portfolio includes anti-tumor and anti-viral, hypoglycemic drugs, animal health products, oral …
  • Sherwin-Williams Co (SHW):企業の財務・戦略的SWOT分析
    Sherwin-Williams Co (SHW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sichuan Kelun Pharmaceutical Co Ltd (002422):医療機器:M&Aディール及び事業提携情報
    Summary Sichuan Kelun Pharmaceutical Co., Ltd. (Kelun) is engaged in manufacturing and distribution of IV Solutions. The company’s products portfolio includes glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringer’s injection, lactated ringer’s injection, compoun …
  • Downer EDI Ltd (DOW)-石油・ガス分野:企業M&A・提携分析
    Summary Downer EDI Limited (Downer) is a diversified services company. The company offers wide range of services such as transport infrastructure, engineering, utility, construction, and maintenance., It also provides mining services such as open-cut mining, crushing, underground mining operations, …
  • Resona Holdings, Inc.:企業の戦略・SWOT・財務情報
    Resona Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Resona Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • The Seibels Bruce Group Inc:企業の戦略・SWOT・財務分析
    The Seibels Bruce Group Inc - Strategy, SWOT and Corporate Finance Report Summary The Seibels Bruce Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Mahle GmbH:企業の戦略的SWOT分析
    Mahle GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Yomeishu Seizo Co Ltd (2540):企業の財務・戦略的SWOT分析
    Yomeishu Seizo Co Ltd (2540) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆